These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 10786259
21. Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial. Association of Black Cardiologists (ABC) Candesartan Study Group. Heart Dis; 2000; 2(6):392-9. PubMed ID: 11728289 [Abstract] [Full Text] [Related]
22. Candesartan cilexetil: in children and adolescents aged 1 to <17 years with hypertension. Hoy SM, Keating GM. Am J Cardiovasc Drugs; 2010; 10(5):335-42. PubMed ID: 20860416 [Abstract] [Full Text] [Related]
23. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension. Bönner G, Fuchs W. Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893 [Abstract] [Full Text] [Related]
30. Achieving quality 24-h blood pressure control with candesartan cilexetil. Meredith P. Blood Press Suppl; 2000 Jun; 1():23-6. PubMed ID: 11059632 [Abstract] [Full Text] [Related]
31. Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure. Meredith PA. Curr Med Res Opin; 2007 Jul; 23(7):1693-705. PubMed ID: 17588300 [Abstract] [Full Text] [Related]
32. Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action. Inada Y, Ojima M, Kanagawa R, Misumi Y, Nishikawa K, Naka T. J Hum Hypertens; 1999 Jan; 13 Suppl 1():S75-80. PubMed ID: 10076925 [Abstract] [Full Text] [Related]
33. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension. Himmelmann A, Keinänen-Kiukaanniemi S, Wester A, Redón J, Asmar R, Hedner T, Effect Study Group. Blood Press; 2001 Jan; 10(1):43-51. PubMed ID: 11332334 [Abstract] [Full Text] [Related]
37. Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man. Malerczyk C, Fuchs B, Belz GG, Roll S, Butzer R, Breithaupt-Grögler K, Herrmann V, Magin SG, Högemann A, Voith B, Mutschler E. Br J Clin Pharmacol; 1998 Jun; 45(6):567-73. PubMed ID: 9663812 [Abstract] [Full Text] [Related]
38. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL. Am J Cardiol; 1998 Oct 15; 82(8):961-5. PubMed ID: 9794352 [Abstract] [Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension--a population analysis. Meineke I, Feltkamp H, Högemann A, Gundert-Remy U. Eur J Clin Pharmacol; 1997 Oct 15; 53(3-4):221-8. PubMed ID: 9476035 [Abstract] [Full Text] [Related]
40. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)]. Baumgart P, Reismann J, Pohlmeyer H, Düsing R. Dtsch Med Wochenschr; 2001 May 11; 126(19):547-50. PubMed ID: 11402910 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]